CHICAGO and WALTHAM, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- The Foundation for Women’s Cancer (FWC), the official foundation of the Society of Gynecologic Oncology (SGO), and TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the third year of their partnership supporting the annual National Race to End Women’s Cancer. The weekend-long event is the FWC’s pinnacle awareness and fundraising event, celebrating survivors, honoring loved ones, creating awareness and supporting women with gynecologic cancers. TESARO is the Presenting Break-Through Sponsor of the 9th annual event, which features a 5K run and 1-mile walk on Sunday, November 4, at Freedom Plaza in Washington, D.C.
“Over the past three years, we have developed a strong partnership with TESARO, reflecting our shared commitment to supporting and inspiring the gynecological cancer community,” said FWC Board of Directors Chair David G. Mutch, M.D., FACOG, Washington University School of Medicine in St. Louis. “TESARO’s ongoing support helps us deliver an entire weekend of events for patients, survivors, family members and friends that are memorable, meaningful and fun.”
“TESARO is excited to continue our partnership with the Foundation for Women’s Cancer to advance our shared mission of improving the lives of women with gynecological cancers. We are proud to contribute to the FWC’s crucial work providing education and support to those touched by cancer,” said Lonnie Moulder, CEO of TESARO. “Each year, we look forward to joining the gynecological cancer community for this incredible and moving event.”
In the U.S. it is estimated that there will be more than 110,000 new cases diagnosed and approximately 32,000 deaths from gynecologic cancers in the during 2018.1The FWC supports survivors and works to raise awareness and research funding to eradicate gynecologic cancers.
Pre-race programing will begin at 7:30 a.m. at 14th Street and Pennsylvania Avenue NW, with the 5K run starting at 9:30 a.m. The event is led by National Race to End Women’s Cancer Co-Chairs Camille Grammer, an endometrial cancer survivor and star on “The Real Housewives of Beverly Hills,” who will walk the route with her team, “Camille’s Crusaders,” and Wendy Ericsson, 2017 “Super Survivor” award recipient and a uterine cancer survivor, who also serves as captain of her team “Wendy’s Warriors.” Registration is now open at endwomenscancer.org.
TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.
About the Foundation for Women’s Cancer Center
The Foundation for Women’s Cancer (FWC) is a 501(c)3 nonprofit organization dedicated to supporting research, education and public awareness of gynecologic cancers. The FWC is the official foundation of the Society of Gynecologic Oncology (SGO). Learn more at foundationforwomenscancer.org.
About the Society of Gynecologic Oncology
The Society of Gynecologic Oncology (SGO) is the premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers. As a 501(c)(6) organization, the SGO contributes to the advancement of women’s cancer care by encouraging research, providing education, raising standards of practice, advocating for patients and members and collaborating with other domestic and international organizations. Learn more at sgo.org.
Join the Movement and Follow Us on Social Media:
Vice President, Corporate Affairs, PR and Advocacy
email@example.com or +1 781-786-7007
For the National Race to End Women’s Cancer:
Kerry Lynn Bohen
Vice President, Brotman Winter Fried - A Sage Communications Company
firstname.lastname@example.org or +1 703-533-4823
1 Cancer Facts and Figures 2018. American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf Published June 2018. Accessed October 4, 2018.